Get started
Australian Clinical Labs LtdAustralian Clinical Labs LtdAustralian Clinical Labs Ltd

Australian Clinical Labs Ltd

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFs
Full chart
Full chart

Compare with Australian Clinical Labs Ltd



Key stats


Market capitalization
‪443.92 M‬ AUD
Dividend yield (indicated)
5.36%
Price to earnings Ratio (TTM)
17.83
Basic EPS (TTM)
0.14 AUD
Net income (FY)
‪32.43 M‬ AUD
Revenue (FY)
‪736.15 M‬ AUD
Shares float
‪156.26 M‬
Beta (1Y)
0.79

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪4.7 K‬
Change (1Y)
−200−4.08%
Revenue / Employee (1Y)
‪156.63 K‬ AUD
Net income / Employee (1Y)
‪6.90 K‬ AUD

Details


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Greg Horan
Website
clinicallabs.com.au
Headquarters
Clayton
Founded
2020
IPO date
May 14, 2021
ISIN
AU0000148496
FIGI
BBG0107G4386
Identifiers
ISIN AU0000148496
Australian Clinical Labs Ltd. engages in the provision of pathology services. It operates through the Pathology segment. The Pathology segment includes pathology/clinical laboratory services provided in Australia. The company was founded in 2015 and is headquartered in Clayton, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


DACE
Dimensional Australian Core Equity Trust Units
Weight0.04%
Market value‪1.96 M‬
DLS
WisdomTree International SmallCap Fund
Weight0.06%
Market value‪642.15 K‬
QOZ
BetaShares FTSE RAFI Australia 200 ETF
Weight0.06%
Market value‪589.95 K‬
GWX
State Street SPDR S&P International Small Cap ETF
Weight0.05%
Market value‪469.53 K‬
DDLS
WisdomTree Dynamic International SmallCap Equity Fund
Weight0.06%
Market value‪236.99 K‬
VETH
Vanguard Ethically Conscious Australian ETF
Weight0.02%
Market value‪148.50 K‬
ISO
iShares S&P/ASX Small Ordinaries Index Fund
Weight0.15%
Market value‪141.52 K‬
DTH
WisdomTree International High Dividend Fund
Weight0.02%
Market value‪138.74 K‬
SSO
State Street SPDR S&P/ASX Small Ordinaries ETF
Weight0.15%
Market value‪28.91 K‬
A300
Global X Australia 300 ETF Exchnage Traded Fund Units
Weight0.02%
Market value‪1.41 K‬

Explore more ETFs 

Frequently asked questions


The current price of ACL is 2.38 AUD — it has decreased by −1.24% in the past 24 hours. Watch Australian Clinical Labs Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Australian Clinical Labs Ltd stocks are traded under the ticker ACL.
ACL stock has fallen by −0.42% compared to the previous week, the month change is a 3.48% rise, over the last year Australian Clinical Labs Ltd has showed a −15.00% decrease.
We've gathered analysts' opinions on Australian Clinical Labs Ltd future price: according to them, ACL price has a max estimate of 3.17 AUD and a min estimate of 2.08 AUD. Watch ACL chart and read a more detailed Australian Clinical Labs Ltd stock forecast: see what analysts think of Australian Clinical Labs Ltd and suggest that you do with its stocks.
ACL reached its all-time high on Dec 29, 2021 with the price of 6.39 AUD, and its all-time low was 1.83 AUD and was reached on May 14, 2026. View more price dynamics on ACL chart.
See other stocks reaching their highest and lowest prices.
ACL stock is 2.55% volatile and has beta coefficient of 0.79. Track Australian Clinical Labs Ltd stock price on the chart and check out the list of the most volatile stocks — is Australian Clinical Labs Ltd there?
Today Australian Clinical Labs Ltd has the market capitalization of ‪441.54 M‬, it has increased by 3.00% over the last week.
Yes, you can track Australian Clinical Labs Ltd financials in yearly and quarterly reports right on TradingView.
Australian Clinical Labs Ltd is going to release the next earnings report on Aug 26, 2026. Keep track of upcoming events with our Earnings Calendar.
ACL earnings for the last half-year are 0.07 AUD per share, whereas the estimation was 0.07 AUD, resulting in a −8.64% surprise. The estimated earnings for the next half-year are 0.10 AUD per share. See more details about Australian Clinical Labs Ltd earnings.
Australian Clinical Labs Ltd revenue for the last half-year amounts to ‪365.40 M‬ AUD, despite the estimated figure of ‪378.48 M‬ AUD. In the next half-year revenue is expected to reach ‪372.10 M‬ AUD.
ACL net income for the last half-year is ‪5.57 M‬ AUD, while the previous report showed ‪20.74 M‬ AUD of net income which accounts for 0.00% change. Track more Australian Clinical Labs Ltd financial stats to get the full picture.
Yes, ACL dividends are paid semi-annually. The last dividend per share was 0.04 AUD. As of today, Dividend Yield (TTM)% is 5.36%. Tracking Australian Clinical Labs Ltd dividends might help you take more informed decisions.
Australian Clinical Labs Ltd dividend yield was 4.50% in 2025, and payout ratio reached 72.89%. The year before the numbers were 4.78% and 99.75% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 9, 2026, the company has ‪4.7 K‬ employees. See our rating of the largest employees — is Australian Clinical Labs Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Australian Clinical Labs Ltd EBITDA is ‪192.61 M‬ AUD, and current EBITDA margin is 27.02%. See more stats in Australian Clinical Labs Ltd financial statements.
Like other stocks, ACL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Australian Clinical Labs Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Australian Clinical Labs Ltd technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Australian Clinical Labs Ltd stock shows the sell signal. See more of Australian Clinical Labs Ltd technicals for a more comprehensive analysis.